Stock Offerings
Secondary · ATM · Shelf · PIPE Guide↗
1,199 results
1199
Total Filings
$7039.3B
Total Raised
101
424B4 Offerings
314
ATM Programs
255
PIPEs
| Date ▼ | Ticker | Sector | Industry | Mkt Cap | Type | Offer Price | Price | vs Offer | Shares | Proceeds | Underwriters | Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17 | SOCGP | — | — | — | Public Offering | — | — | — | — | — | Barclays | View filing → |
| Aug 17 | MVIS | Technology | Hardware, Equipment & Parts | $37M | Public Offering |
$2.50
floor
|
$1.60 | -36.0% | 6.8M | $17M | — | View filing → |
| Aug 17 | ABVC | Healthcare | Biotechnology | $29M | Public Offering | — | $1.13 | — | 1.0M | — | — | View filing → |
| Aug 17 | ABVC | Healthcare | Biotechnology | $29M | Public Offering | — | $1.13 | — | 11.7M | — | — | View filing → |
| Aug 17 | ABVC | Healthcare | Biotechnology | $29M | Public Offering | — | $1.13 | — | 226K | — | — | View filing → |
| Aug 17 | ABVC | Healthcare | Biotechnology | $29M | Public Offering | — | $1.13 | — | 3.4M | — | — | View filing → |
| Aug 14 | DYAI | Healthcare | Biotechnology | $15M | PIPE |
$0.80
floor
|
$0.42 | -47.7% | 3.6M | $3M | — | Registered direct offering of 3.625M shares at $0.795/share with concurrent warrant private placement for ~$2.9M gross proceeds. |
| Aug 14 | BIAFW | — | — | — | PIPE |
$0.47
floor
|
— | — | 8.5M | $4M | — | Private placement of 8.46M pre-funded warrants at $0.4657 per warrant to purchase common stock. |
| Aug 14 | SKYE | Healthcare | Biotechnology | $7M | PIPE |
$36.00
floor
|
$1.67 | -95.4% | — | — | — | 8-K filing describes Skye Bioscience acquisition of Redx Pharma; no securities offering details provided. |
| Aug 14 | OTLK | Healthcare | Biotechnology | $120M | Public Offering |
$0.99
floor
|
$0.64 | -35.4% | 55.6M | $55M | Piper Sandler | OTLK offering 55.6M shares at $0.99 with accompanying warrants, raising $55M gross proceeds. |
| Aug 14 | VUZI | Technology | Consumer Electronics | $244M | ATM |
$2.62
floor
|
$2.94 | +12.2% | — | $100M | Jefferies | VUZI offering up to $100M in common stock at-the-market through Jefferies at $2.62/share. |
| Aug 14 | JZ | Consumer Defensive | Education & Training Services | $719,814 | Public Offering |
$2.49
floor
|
$0.45 | -81.8% | 12.0M | $30M | — | Jianzhi Education offering 12,000,000 ADSs at $2.49 per ADS, representing 21.6 billion Class A ordinary shares. |
| Aug 14 | MVIS | Technology | Hardware, Equipment & Parts | $37M | Public Offering | — | $1.60 | — | — | — | — | MicroVision offering common stock with warrants and pre-funded warrants; specific prices and share quantities not yet determined in preliminary filing. |
| Aug 13 | HCWC | Consumer Defensive | Packaged Foods | $7M | PIPE |
$0.27
floor
|
$11.33 | +4096.3% | 2.6M | $692,671 | — | Healthy Choice Wellness exchanged $692,671 principal for 2,565,450 Class A shares at $0.27/share. |
| Aug 13 | SVV | Consumer Cyclical | Specialty Retail | $1.4B | Public Offering |
$10.25
floor
|
$9.34 | -8.9% | 20.0M | $205M | J.P. Morgan, Goldman Sachs, Jefferies, UBS, Wells Fargo, William Blair | Savers Value Village offers 20M shares at $10.25/share for $205M gross proceeds by selling stockholders. |
| Aug 13 | VEEAW | — | — | — | ATM | — | — | — | 62.2M | $4M | — | Up to $4,353,000 of common stock in at-the-market offering at $0.1259 per share via Roth Capital Partners. |
| Aug 13 | MDXH | Healthcare | Medical - Diagnostics & Research | $29M | Public Offering |
$0.45
floor
|
$0.57 | +24.5% | 44.1M | $20M | — | MDxHealth offering 44.1M ordinary shares at $0.454/share for approximately $20M gross proceeds. |
| Aug 13 | DYAI | Healthcare | Biotechnology | $15M | Public Offering |
$0.80
floor
|
$0.42 | -47.7% | 3.6M | $3M | — | DYAI offering 3.625M shares at $0.795/share for $2.88M gross proceeds in registered direct offering. |
| Aug 13 | RKLB | Industrials | Aerospace & Defense | $42.8B | ATM | — | $73.95 | — | — | $1.9B | Deutsche Bank, Wells Fargo | Rocket Lab offers up to $1.94B in common stock through equity distribution agreement with Deutsche Bank and Wells Fargo. |
| Aug 13 | CRIS | Healthcare | Biotechnology | $2M | Public Offering |
$1.50
floor
|
$0.83 | -44.7% | 335K | $502,502 | — | Curis offering 335,001 shares at $1.50 per share with pre-funded and common warrants in combination. |
Data sourced from SEC EDGAR 424B4, 424B5, and 8-K filings. IPOs hidden by default.
Learn more →